GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: 1314 TH | Bayer 5312 | Trecator®
ethionamide is an approved drug (FDA (1965))
Compound class:
Synthetic organic
Comment: Ethionamide is a thioamide compound with potent antibacterial activity against mycobacteria. It is used in the treatment of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). Ethionamide inhibits mycobacterial fatty acid synthesis by targeting InhA (an enoyl-acyl carrier protein reductase) [2], following intracellular activation, by the monooxygenase EthA, in Mycobacterium tuberculosis [1].
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| The MIC for in vitro antimycobacterial activity is 0.25 μg/ml against Mycobacterium tuberculosis H37Rv and 0.25-4.0 μg/ml against a panel of drug-sensitive and drug-resistant M. tuberculosis isolates [3]. |